Home
Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc. Market Share Analysis for May 2026

With experience in developing therapeutics for chronic liver diseases and viral infections, we are building best-in-class drug candidates.

Health > Biotechnology and Pharmaceuticals

Domainaligos.com

Year Founded2018

Employees51 - 200

Annual Revenue$2M - $5M

Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc. (including company regionals)

aligos.com

See more website traffic and engagement information

Aligos Therapeutics, Inc. Revenue up to May 2026 is 2M - 5M

revenue generated by Aligos Therapeutics, Inc. top domains

Aligos Therapeutics, Inc. top domains revenue over 3 years

Revenue for Aligos Therapeutics, Inc. top domains

aligos.com2M - 5M

See more with Sales Intelligence

Total visits to Aligos Therapeutics, Inc.'s top domains

Understand Aligos Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aligos.com17.8K

See more with Sales Intelligence

Avg. visit duration in Aligos Therapeutics, Inc.'s top domains

Analyze Aligos Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

aligos.com00:01:24

See more with Sales Intelligence

Avg. pageviews on Aligos Therapeutics, Inc.'s top domains

See how Aligos Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aligos.com2.82

See more with Sales Intelligence

Aligos Therapeutics, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

astellasgenetherapies.comCompany NameAstellas Gene TherapiesEmployees201 - 500HQUnited States, California, San FranciscoAnnual revenue$75M - $100MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Aligos Therapeutics, Inc.

These are the website technologies, by industry, used by Aligos Therapeutics, Inc. top domains

Conversion & Analytics (19)

Google Analytics

Advertising (12)

Google Adsense

Marketing (7)

Google Marketing Platform

Widget (4)

Twemoji

More Technologies

9

See all

News & Signals from Aligos Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAligos Therapeutics, Inc. sells assets to Amoytop in the amount of $445M.Aligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal.

NewsAligos Therapeutics, Inc. is developing pevifoscorvir sodium in Greater China for chronic hepatitis B virus infection on Apr 16th '26.California-based liver and viral disease specialist Aligos Therapeutics (Nasdaq: ALGS) has entered into an exclusive license agreement with Xiamen Amoytop Biotech to develop and commercialize pevifoscorvir sodium in Greater China for chronic hepatitis B virus (HBV) infection, the company announced yesterday.

NewsAligos Therapeutics, Inc. is developing ALG-170675 on Jul 1st '23.Aligos and Amoytop formed a research collaboration in 2023, and were already partnered on development of ALG-170675, a preclinical antisense oligonucleotide program targeting chronic HBV.